2nd Quarter - Report

ARNOLD & PORTER KAYE SCHOLER LLP for GENETIX BIOTHERAPEUTICS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues and legislation related to access to gene therapies and treatment of rare diseases.

LobbyistCovered position, as disclosed
LUKE ALBERT —
RON KIND —
BOBBY MCMILLIN —
SONJA NESBIT —
EUGENIA PIERSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues and legislation related to access to gene therapies and treatment of rare diseases.

LobbyistCovered position, as disclosed
LUKE ALBERT —
RON KIND —
BOBBY MCMILLIN —
SONJA NESBIT —
EUGENIA PIERSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues related to regulatory incentives for rare disease therapies.

LobbyistCovered position, as disclosed
BOBBY MCMILLIN —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.